‘Middlemen’ Markups Are Penalizing Patients, Says AAM
Cash Prices For Generic Drugs Are Substantially Higher Than Manufacturer Prices
The Association for Accessible Medicines has launched its Markup Madness campaign, which seeks to draw attention to the disparity in cost between generic drugs upon entry to the supply chain and when purchased in pharmacies.
You may also be interested in...
The US Association for Accessible Medicines’ annual report into generic and biosimilar savings has documented another year of increased cost savings thanks to off-patent drugs, but says some patients are still overpaying for their generic medicines.
IQVIA has published a white paper examining the growing reliance on pharmacy discount cards to pay for prescriptions in the US.
The closure of a Teva manufacturing plant in California has raised concerns around access a number of medicines, something the End Drug Shortages Alliance says could be avoided through increased market transparency.